C Partners Holding’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

C Partners Holding’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-26,000	Closed	-$1.54M	–	32
2015 Q2	$1.54M	Hold	26,000	–	–	0.72%	30
2015 Q1	$1.62M	Hold	26,000	–	–	0.52%	35
2014 Q4	$1.5M	Buy	+26,000	New	+$1.45M	0.48%	37

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

C Partners Holding's TEVA Position: Q3 2015 in Review

C Partners Holding sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2015, closing a stake of 26,000 shares — an estimated $1.54M sold.

C Partners Holding first reported a position in TEVA in Q4 2014 and held it in 3 quarters. The position peaked at $1.62M in Q1 2015. 824 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

C Partners Holding reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2015 after selling out during the quarter.
C Partners Holding sold 26,000 Teva Pharmaceutical Industries Limited shares in Q3 2015, an estimated $1.54M.
C Partners Holding first reported a position in Teva Pharmaceutical Industries Limited in Q4 2014 and held it in 3 quarters.
C Partners Holding's Teva Pharmaceutical Industries Limited position peaked at $1.62M in Q1 2015.
824 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2015.

Based on C Partners Holding's 13F filing for Q3 2015, filed 12 Nov 2015.